Genomate Health

Kidney cancer doesn’t just affect adults—it can impact children too. Awareness, early detection, and research are crucial in improving outcomes for all patients. Let’s use this month to support those affected, get informed, and be part of the fight against kidney cancer. #WorldKidneyDay #KidneyCancerAwareness

On International Women’s Day, we celebrate the strength and resilience of all the amazing women around the world, but we also need to talk about a pressing health concern. Cancer rates in women under 50 are rising, with breast cancer and colorectal cancer being a significant concern. What does this mean for young women? It’s time to change the narrative—cancer isn’t just something to worry about “later in life.” Here’s what every woman should know: ??♀? Be aware of your body: know what’s normal for you. ??♀? Speak up: if you notice changes in your breasts (lumps, pain, or anything unusual), don’t hesitate to bring it up with a doctor. ? Follow up: if symptoms persist, push for further evaluation, even if initial imaging is normal. Early detection saves lives! #WomenDay #GenomateHealth

At Ci4CC CIGR 2025, Dr. Istvan Petak will tackle one of the biggest challenges in cancer treatment: the overwhelming complexity of tumor genetics. With each tumor carrying an average of 5 driver alterations among millions of potential mutations in 700+ cancer driver genes, gathering the necessary clinical evidence through traditional methods would take an astonishing 14.4 million years. ? So, how do we solve this? Next-generation deterministic, multidimensional AI-driven clinical decision support systems are changing the game—enabling evidence-based, personalized treatment planning in real time. Join Dr. Petak at Ci4CC CIGR 2025 for a deep dive into how computational intelligence solutions, like Genomate, are delivering the promise of precision oncology. Learn more & register: https://lnkd.in/d4cwC_eH #CIGR2025 #Ci4CC #PrecisionOncology #CancerResearch #GenomateHealth

?? Meet the Speakers of Equity Thursday – March 13, 2025! At the upcoming?Equity Thursday?we are bringing together thought leaders in?MedTech and venture capital?to discuss the sector’s breakthrough potential. ???Introducing: Istvan Petak MD, PhD?– physician-scientist, molecular pharmacologist, and a pioneer in?precision oncology ???Leader in Precision Oncology?– Co-authored over?200 scientific publications?in molecular pharmacology and predictive molecular diagnostics. ???Founder & Innovator?– Co-founded?Oncompass Medicine?(2008) and?Genomate Health?(2022), advancing?AI-driven molecular diagnostics. ???Award-Winning Researcher?– Recipient of the?Dénes Gábor Innovation Award (2012), the?Breakthrough Innovations (AI) in Oncology Award (ASCO), and the?Future Unicorn Award (DIGITALEUROPE). ???Global Impact?– His AI-driven technology was recognized by?President Ursula von der Leyen as the next scientific revolution in medicine?and has been part of the?Mayo Clinic Platform Accelerate & NVIDIA Inception Program. Dr. Peták’s work has?revolutionized cancer diagnostics and treatment decisions, shaping the future of?AI-driven personalized medicine. ???Join us at Equity Thursday to hear from Dr. István Peták and other experts as they explore the opportunities in MedTech innovation and investment. ???Date:?March 13, 2025 ???Venue:?Brody House, Budapest ???Register now:?https://lnkd.in/dvuQKrP2

HPV-related cancers are preventable, yet too many people remain unaware of the risks and the power of vaccination and screening. Prevention starts with education, action, and access. By increasing awareness, ensuring widespread vaccination, and promoting regular screenings, we can eliminate HPV-related cancers for future generations. This #InternationalHPVAwarenessDay, let’s commit to spreading knowledge, breaking stigma, and protecting lives. ?#CancerPrevention #EarlyDetection #GenomateHealth

Over 300 million people worldwide live with a rare disease. Each journey is unique, often marked by delayed diagnoses, limited treatment options, and countless challenges. Today, we shine a light on their resilience and the urgent need for innovation in healthcare. We’re committed to advancing precision medicine to ensure no patient, no matter how rare their condition, is left behind. By tailoring treatments to each individual’s unique genetic and molecular profile, we aim to bring hope and solutions to those facing rare diseases. #GenomateHealth #PrecisionMedicine

Why is cancer so hard to treat? Cancer isn’t one disease, it’s thousands of unique molecular variations.? We know there are 733 driver genes and over 6 million somatic mutations in cancer. Each tumor typically harbors a unique combination of 4-5 mutations out of these 6 million. Now, imagine we tried to test every possible combination of mutations and cancer types through clinical trials to determine the most effective therapies. Dr. Istvan Petak, our CEO, CSO and founder, ran the numbers and the result is mind-blowing: the estimated time needed? 14.4 million years. We believe the future of cancer treatment lies in computational intelligence-driven precision oncology, with solutions like Genomate, which can analyze vast datasets and predict the most effective treatment for each patient in real time. Instead of waiting millions of years, we can make data-driven decisions today. #PrecisionOncology #CancerResearch #GenomateHealth

This Valentine’s Day, let’s celebrate more than romantic love - let’s honor the selfless love of organ, blood, tissue, and stem cell donors. Every donor is a hero, a symbol of love in its purest form, offering others a second chance at life. Whether through a simple blood donation or registering as an organ donor, your actions could save a life. Your decision to give can save lives, transform families, and create a ripple of love that lasts forever. Register today: https://lnkd.in/eDr2WFd

Women represent only 33% of researchers globally, and even fewer hold leadership roles in STEM fields. Today is International Day of Women and Girls in Science, a powerful reminder to continue advocating for equity and opportunities in science, so the next generation of women scientists can thrive, innovate, and lead. At Genomate Health, we are fortunate to work alongside extraordinary women whose contributions are essential to our mission of transforming cancer care through precision oncology. Learn more about their stories and role models: https://lnkd.in/d-BEzQ9B To all the women making breakthroughs across STEM: we see you, we celebrate you, and we thank you ?? #InternationalDayOfWomenInScience #WomenInSTEM #GenomateHealth

Each cancer journey is as unique as the person facing it. From the molecular makeup of a tumor to the stories, strengths, and struggles of every patient, no two experiences are the same. This #WorldCancerDay, we celebrate the uniqueness that unites us in the fight against cancer. At #GenomateHealth, we honor individuality by empowering clinicians to tailor treatments to each patient’s unique genetic profile, ensuring that care is as personal as the journey itself. Together, we’re advancing precision oncology to transform lives. Let’s stand united by what makes us unique, working for a future where everyone facing cancer has access to better outcomes, better care, and better hope.